# METHYLPREDNISOLONE ACETATE
> **ANDA214870** · Abbreviated New Drug Application (Generic) · Sponsor: WILSHIRE PHARMS INC · Approved 2023-01-03
## Drug
- **FDA Application Number:** ANDA214870
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHYLPREDNISOLONE ACETATE
- **Generic name:** METHYLPREDNISOLONE ACETATE
- **Active ingredients:** METHYLPREDNISOLONE ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** WILSHIRE PHARMS INC
- **Manufacturer:** Sandoz Inc.
- **First approval:** 2023-01-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214870)
---
*MORVS · CC0 1.0*